Ultrahuman is a metabolic-health wearables company best known for the Ultrahuman Ring AIR, an AI-powered smart ring competing directly with Oura. The platform tracks sleep, heart-rate variability, body temperature, activity and recovery, and uses AI to translate that data into personalized insights, scores and coaching. Beyond the ring, Ultrahuman builds a broader ecosystem including continuous glucose-monitoring (M1) and home health products, positioning itself as a metabolic-fitness platform rather than a single device. Founded in 2019 and headquartered in Bengaluru with operations in the US and Europe, Ultrahuman has raised more than $100 million across multiple rounds. Its $35 million Series B in March 2024 was co-led by existing investors Blume Ventures, Steadview Capital and Nexus Venture Partners, with participation from Alpha Wave Global and Zomato founder Deepinder Goyal. The company launched the Ring Pro in the US after receiving market clearance, marking a comeback against Oura.
Ultrahuman
ActiveAI-driven smart ring and metabolic health wearables platform
Total raised
$52.5M
2 rounds
Stage
Series A
Team
201-500
since 2019
Pricing
Freemium
free plan
Founded
2019
Bengaluru, India
Agent-ready
—
Ring AIR smart ring
AI sleep and recovery analysis
Heart-rate and HRV tracking
Continuous glucose monitoring (M1)
No mandatory subscription
Body temperature and activity tracking
Personalized AI health insights
Metabolic fitness ecosystem
10/100
Early
MCP server
Public API
Webhooks
OAuth 2.0
SDKs
No public agent surfaces detected yet.
— Series A $17.5M incl. Alpha Wave Incubation +3
— Series B $35M incl. Alpha Wave Global +4
Capital network
$103M raised ·6 backers·10 network links
- Backers6
- Shared portfoliocompanies these backers also fund
- Extended networkfunds that co-invest alongside them
Pearl Health
AI value-based care platform for primary care providers
AI AnalyticsAI Healthcare
Commure
AI Healthcare
Innovaccer
AI Healthcare
Truveta
AI Healthcare
Terray Therapeutics
Generative AI and ultra-high-throughput chemistry for small-molecule drug discovery
AI HealthcareDrug Discovery
Genesis Molecular AI
Generative AI for small-molecule drug discovery
AI HealthcareDrug Discovery
- Does Ultrahuman require a subscription?
- No. The Ring AIR works without a mandatory subscription, unlike some competitors.
- How much has Ultrahuman raised?
- More than $100 million, including a $35M Series B in March 2024.
- What is M1?
- M1 is Ultrahuman's continuous glucose monitoring product within its metabolic health platform.
Discussion
Sign in to join the discussion.
Sign inExplore more around Ultrahuman
Contextual paths to related AI startups, deals and rankings.